Objectives-The purpose of this study was to evaluate the application of a new elastographic technique, acoustic radiation force impulse (ARFI) imaging, and its diagnostic performance for characterizing breast lesions.
B
reast physical examination, mammography, and conventional ultrasound (US) imaging are the triad of commonly performed methods for characterization of suspicious breast masses. Conventional US has always played a key role in the diagnosis of breast diseases, particularly in dense breasts of most Chinese women. 1, 2 However, it is known that there are several inherent disadvantages with conventional US. The most important ones are that conventional US is highly operator dependent and that it lacks reproducibility.
Elastography has emerged as a useful adjunct tool for conventional US diagnosis, that has shown effectiveness for detection of malignancy within breast lesions. 3, 4 Acoustic radiation force impulse (ARFI) imaging is a newly developed elastographic method based on US imaging, which characterizes the relative differences in tissue stiffness by measuring small (1-10 lm) displacements resulting from applied US radiation force. 5 To date, many studies have proved ARFI imaging to be valuable for the diagnosis of liver and thyroid diseases, among others, [6] [7] [8] [9] but there is very limited knowledge regarding the use of ARFI imaging for breast lesion assessment. 10, 11 The aim of this study was to evaluate the application of a new elastographic technique, ARFI imaging (composed of Virtual Touch tissue imaging [VTI] and Virtual Touch tissue quantification [VTQ] ; Siemens Medical Solutions, Mountain View, CA) and its diagnostic performance for characterizing breast lesions by creating a scoring system consisting of parameters derived from VTI and VTQ.
Materials and Methods

Patients
This study was approved by the Institutional Review Board of Renji hospital. From June 2011 to August 2015, 142 consecutive female patients with 186 breast lesions previously detected by conventional US, classified as American College of Radiology Breast-Imaging Reporting and Data System (BI-RADS) categories 3 to 5, according to the BI-RADS classification scheme, 12 underwent ARFI imaging. Forty-two patients with 60 breast lesions were excluded because of a lack of pathologic results; therefore, data from 100 female patients with 126 breast lesions who underwent histopathologic examinations of specimens obtained by surgical excision or US-guided core needle biopsy were included in this prospective study.
Imaging Technique
Conventional breast US and ARFI examinations were performed with an Acuson S2000 US system (Siemens Medical Solutions). On this system, ARFI technology consists of the following 2 implementations: Virtual Touch tissue imaging depicts the relative stiffness by providing a grayscale map in the selected region of interest (ROI). The stiffer a tissue, the darker the VTI image. This depiction is a qualitative response. Virtual Touch tissue quantification refers to a quantitative assessment of the tissue stiffness by providing VTQ values (shear wave velocity [SWV] , in meters per second) of a lesion, which is obtained by placing a fixed-size ROI (5 3 6 mm) on the lesion. The stiffer a tissue, the greater the SWV.
All patients were first scanned by a linear array multifrequency (7-14 MHz) transducer (14L5) to fix the location and size of breast lesions and obtain the US characteristics. Then in the ARFI mode, VTI and VTQ were performed with a linear array transducer (9L4, 7-9 MHz). A user-defined ROI for the VTI examination was selected by the operator and was standardized to include the mass and adequate surrounding normal breast tissue. When the proper images were obtained after a few seconds of immobilization, the update button was pressed to catch the VTI patterns and calculate the VTI-to-Bmode area ratio 3 times for each lesion. Two screens were used, with the B-mode US image of the lesion on the left and the corresponding VTI grayscale map on the right, thus assisting the operator in finding the correct position. Then, switching to the VTQ mode, VTQ values were measured 3 times at each site by putting the entire fixed-size ROI inside the lesion (internal value), tangential to the boundary of the lesion (marginal value), in the surrounding normal breast tissue (surrounding value), and in the subcutaneous fat tissue (fat value), taking care not to include any vessels or calcifications within the ROI. The surrounding ROI was placed in the surrounding normal breast tissue at a distance of at least 1 cm from the tumor. Mean values of the 3 measurements were used as VTQ values for each breast lesion. The transducer was applied with light pressure, keeping steady and perpendicular to the skin opposite the lesion to be investigated. All measurements were obtained during a breath hold after subtle inspiration. A complete standardized B-mode US examination and ARFI imaging were performed by a sonographer with more than 4 years of experience in breast US.
According to Tozaki et al, 10 the VTI images were classified into the following 4 different patterns (compared to lesions corresponding to B-mode images): no visible lesions (pattern 1; Figure 1 ), lesions that were mainly bright inside (pattern 2; Figure 2 ), lesions that contained both bright and dark areas (pattern 3; Figure 3 ), and lesions that were mainly dark inside (pattern 4). In addition, pattern 4 was subdivided into 4a (dark area same as on the B-mode image) and 4b (dark area larger than on the B-mode image) according to the difference in the width of pattern 4 lesions between ARFI and B-mode images, which was 1.5 mm at the maximum for 4a lesions ( Figure 4 ) and 1.8 mm at the minimum for 4b lesions ( Figure 5 ).
Data Analyses
Virtual Touch tissue imaging patterns were evaluated by a v 2 test. A statistical difference between benignity and malignancy was compared by a nonparametric Mann-Whitney U test. The diagnostic performance of VTI patterns, mean area ratio, VTQ values, and ARFI values was evaluated by a receiver operating characteristic curve analysis and expressed in terms of sensitivity, specificity, and accuracy. All tests were 2 sided, and P < .05 was considered statistically significant. All statistical analyses were performed with the SPSS version 13.0 for Windows software package (IBM Corporation, Armonk, NY).
Results
The ages of the 100 patients included in the study ranged from 18 to 81 years (mean, 43.8 years. The maximum diameters of the lesions ranged from 6.8 to 25.8 mm (mean 6 SD, 14.6 6 4.2 mm). Pathologic analysis revealed 40 lesions in the malignant group and 86 lesions in the benign group. Malignant lesions included invasive ductal carcinoma (n 5 29), invasive ductal carcinoma containing ductal carcinoma in situ (n 5 6), invasive cribriform carcinoma (n 5 1), ductal carcinoma in situ (n 5 2), and intraductal carcinoma with microinvasion (n 5 2). Benign lesions included fibrocystic changes (n 5 16), fibroadenomas (n 5 62), intraductal papillomas (n 5 5), and granulomatous mastitis (n 5 3). The mean size of the malignant lesions was 16.2 6 4.4 mm (range, 9.2-24.8 mm), and that of the benign lesions was 13.8 6 3.9 mm (range, 6.8-25.8 mm).
Different VTI patterns observed in benign and malignant breast lesions are summarized in Table 1 . For the VTI patterns of the breast lesions compared to pathologic results, of the 40 malignant lesions, 31 (77.5%) had pattern 4a or 4b, and 9 (22.5%) had pattern 1, 2, or 3; and of the 86 benign lesions, 80 (93.0%) had pattern 1, 2, or 4, and 6 (7.0%) had pattern of 4a. All pattern 4b lesions were malignant. There were statistical differences between the groups (P < .001). When the optimal cutoff level was set between patterns 4a and 4b, the VTI pattern predicted malignancy with sensitivity of 50.0%, specificity of 100.0%, accuracy of 84.1%, and an area under the curve (AUC) of 0.867.
The mean VTI-to-B mode area ratio and VTQ values were calculated and are shown in Table 2 . Regarding the quantitative analysis, the mean area ratio, internal value, and marginal value of benign lesions were statistically lower than those of malignant lesions (all P < .001). The cutoff values for the mean area ratio, internal value, and marginal value for malignancy were estimated to be 0.645, 7.74 m/s, and 1.57 m/s, respectively. These statistically significant parameters were used to construct a scoring system to evaluate the diagnostic performance of ARFI (Table 3) . Depending on the correlation between the described diagnostic indices and the probability of malignancy, 0 to 2 points were given for each index. As a result, a total of 0 to 6 points was possible for each breast lesion on ARFI imaging. Lesions scoring from 0 to 3 points were classified as benign; otherwise, they were classified as malignant. The cutoff point for the ARFI scoring system was estimated to be between 3 and 4 points, with sensitivity of 77.5%, specificity of 96.5%, accuracy of 90.5%, and an AUC of 0.933 ( Figure 6 ). The diagnostic performance of VTI patterns and quantitative parameters and ARFI was evaluated by a receiver operating characteristic curve analysis and is shown in Table 4 .
Discussion
Acoustic radiation force impulse technology represents a relatively new imaging method, which is able to noninvasively assess the viscoelastic properties of target tissues. Without any need for external compression, its quantitative implementation, called VTQ, is the world's first application for obtaining a numeric SWV value related to tissue stiffness at a precise image-based anatomic location, making it more operator independent, objective, and reproducible. 13, 14 This study was conducted to investigate the characteristic features of VTI and quantitative parameters of VTQ and the clinical usefulness of the ARFI technology in differential diagnosis of breast lesions. Based on the results of this study, VTI patterns were mainly 1 to 3 in benign lesions (80 of 86 [93.0%]), whereas the pattern was mainly 4 in malignant lesions (31 of 40 [77.5%]). In visual evaluations of pattern 4 lesions, 17 were rated as pattern 4a and 20 as 4b. All pattern 4b lesions were malignant.
With regard to SWV measurements, VTQ values may provide no numeric value when the individual velocity estimates between tracking beams vary too much to provide a valid reading, appearing as X.XX. Possible explanations for this result includes the following: (1) measurements were out of the tolerable range of the system for SWV calculation because of very high elasticity of the tissue; (2) tissue inside the ROI was heterogeneous, making it difficult for the system to identify the shear wave peak consistently as it propagated; and (3) the shear wave generated in simple fluids, such as a simple cyst or gallbladder, was too low to detect. 13, 15 According to the manufacturer of the US machine (Siemens Medical Solutions), a VTQ value of X.XX represents a velocity faster than 9 m/s when the VTI image appears dark.
An X.XX result occurred in 22 lesions (acquired correctly, and X.XX was repeatedly obtained) in the study. We discovered in practice that the VTQ values in lesions have obvious differences in different sections; therefore, to ensure comparability and repeatability of the VTQ values obtained, we used different sections to measure. When the repeated non-numeric result X.XX was designated as an indicator of malignancy, the sensitivity, specificity, and accuracy were 63.4%, 100%, and Figure 6 . Receiver operating characteristic curve analysis of different diagnostic indices to evaluate the diagnostic performance of ARFI for discrimination between benign and malignant breast lesions. The AUC value for the ARFI scoring system is maximal. 89.5%, respectively. The quantitative VTQ analysis can yield reproducible diagnostic information on solid breast masses and serve as an effective diagnostic tool for differentiating benign from malignant breast lesions. In our study, we created the combined diagnostic indices from qualitative and quantitative ARFI analyses to determine the probability of malignancy, and a of 0-to 6-point scoring system was developed (Figure 7) . According to the receiver operating characteristic curve analysis, the AUC of the ARFI scoring system combining VTI and VTQ diagnostic indices was maximal, improving the diagnostic performance of ARFI for discrimination between benign and malignant breast lesions. On the basis of the results of this study, we can estimate the diagnostic value of elastography because a good correlation was found between the elastographic scores and the histologic results, with sensitivity of 77.5%, specificity of 96.5%, accuracy of 90.5%, and an AUC of 0.933. However, our study had certain limitations. The main problem remained the overlap of ARFI values between the different histologic groupings. This feature has also been described in studies on elastography of liver fibrosis. 16 In addition, the combined diagnostic performance of conventional US with ARFI was not evaluated. In general, it would be more meaningful to evaluate the diagnostic efficacy of the combined use of conventional US and ARFI in the differentiation of breast lesions. A guideline for the combination of conventional US and ARFI diagnostic indices to improve benign and malignant differentiation is necessary.
In conclusion, the application of ARFI technology using VTI patterns and the mean area ratio in combination with meaningful VTQ values has shown promising results by noninvasively providing substantial complementary information and could potentially serve as an effective diagnostic tool for differentiation between benign and malignant breast lesions.
